- Hindi News
- Shares Of Amy Organics Are Listed With A Premium Of About 48% And Vijaya Diagnostics With A Premium Of 2%.
Mumbai7 hours ago
- copy link
2 more new shares have been entered in the stock market. Shares of specialty chemical maker Amy Organics and healthcare chain Vijaya Diagnostic Center have been listed on the exchange.
Shares of Amy Organics got listed with a premium of around 48% against the issue price of Rs 610. The share of Amy Organics is listed at Rs 902 per share on BSE and Rs 910 per share on NSE. On the other hand, the stock of Vijaya Diagnostics is listed with a premium of 2%. The stock got listed on BSE at 542.30 against the issue price of Rs 531. The company’s stock was listed on NSE at 540 with a premium of 1.69%.
Amy Organics issue was subscribed 64.54 times
Amy Organics’ IPO opened on September 1 and closed on September 3. The issue was subscribed 64.54 times. According to the National Stock Exchange, Amy Organics Public Offering had received bids of 422.22 crore shares against a total issue size of 65.42 lakh shares.
Issued new shares worth Rs 200 crore
The company has issued new shares worth Rs 200 crore in the issue. Apart from this, the promoters and existing shareholders have sold 60.6 lakh shares through off for sale (OFS). The company has raised Rs 570 crore through IPO.
Funds will be used to pay off debt
The company will use the funds raised through its IPO to repay the debt of Rs 140 crore. At the same time, the fund will be used to meet the working capital requirements and also for general corporate needs.
Along with research and development of specialty chemicals, the company also does manufacturing related to it. The company also exports pharma intermediates to multinational pharma companies in markets like Europe, China, Japan, Israel, USA, UK. In the last financial year, the revenue of Amy Organics had increased to Rs 340.61 crore. Net profit increased from Rs 27.47 crore to Rs 53.99 crore.
IPO was subscribed 4.54 times
Healthcare chain Vijaya Diagnostic’s issue opened on September 1 and closed on September 3. The IPO did not receive a very good response from the investors. The IPO was subscribed 4.54 times till the last day. This IPO was purely Offer for Sale (OFS). In which the existing promoters and investors have sold their shares.
35% was reserved for common investors
50% of the IPO is reserved for Qualified Institutional Buyers (QIBs) and 35% for retail investors. The remaining 15% is reserved for non-institutional buyers.
ICICI Securities, Edelweiss Financial Services and Kotak Mahindra Capital Company have been appointed as investment bankers for the IPO.
Kedara Capital funded Vijaya Diagnostics provides pathology and radiology testing services through its large network. It has 80 diagnostic centers and 11 reference laboratories in Andhra Pradesh, Telangana, Kolkata and NCR. The company’s profit increased to Rs 84.91 crore in the financial year 2020-21. Its total income had increased to Rs 388.59 crore. While the profit in the financial year 2019-20 was Rs 62.5 crore.